98%
921
2 minutes
20
Objectives: This study aimed to report our experience and explore optimal surgical interventions for treating retained products of conception (RPOC) following second and third-trimester pregnancies.
Material And Methods: Medical records of women who underwent either ultrasound-guided dilatation and curettage (D&C) or hysteroscopic electroresection of RPOC at the Fourth Hospital of Shijiazhuang, Hebei province, China, between 2018 and 2022 were retrospectively reviewed. The patients were divided into three groups based on surgical methods and intervention timing. Group A underwent D&C within two weeks to one month after diagnosis (n = 60), Group B had hysteroscopic electroresection within the same timeframe (n = 60), and Group C underwent hysteroscopic electroresection within 1 to 2 months after diagnosis (n = 60). Intraoperative conditions and postoperative complications were compared among three groups.
Results: Mean surgical times were 25.20 ± 7.70 minutes in Group A, 39.38 ± 9.25 minutes in Group B, and 24.50 ± 7.49 minutes in Group C, with significant differences between Groups A and B, as well as B and C (p = 0.0000). Intraoperative bleeding volumes were 128.62 ± 13.15 mL in Group A, 79.35 ± 11.23 mL in Group B, and 30.18 ± 9.85 mL in Group C, showing significant intergroup differences (p = 0.0000). Secondary surgeries occurred in 12 cases in Group A, one case in Group B, and none in Group C (p = 0.0023). The rate of postoperative intrauterine adhesion (IUA) was highest in Group A (p = 0.0012). Intraoperative complications occurred in one case in Group A, two cases in Group B, and none in Group C.
Conclusions: Hysteroscopic electroresection for RPOC within the specified timeframes resulted in shorter operation times, reduced bleeding, lower IUA rate, and fewer secondary surgeries compared to D&C or earlier electroresection.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5603/gpl.102509 | DOI Listing |
Ginekol Pol
September 2025
Department of Gynecology, The Fourth Hospital of Shijiazhuang, Shijiazhuang City, Hebei Province, China.
Objectives: This study aimed to report our experience and explore optimal surgical interventions for treating retained products of conception (RPOC) following second and third-trimester pregnancies.
Material And Methods: Medical records of women who underwent either ultrasound-guided dilatation and curettage (D&C) or hysteroscopic electroresection of RPOC at the Fourth Hospital of Shijiazhuang, Hebei province, China, between 2018 and 2022 were retrospectively reviewed. The patients were divided into three groups based on surgical methods and intervention timing.
Objective: The objective of this study was to evaluate the efficacy of hysteroscopic electroresection in the treatment of atypical endometrial hyperplasia and to determine the prognostic factors.
Methods: 226 patients with endometrial dysplasia treated in hospital from January 2021 to August 2022 were selected and divided into control group (113 cases) and study group (113 cases) according to different treatment methods selected by the patients themselves. The control group received curettage plus conventional progesterone treatment, while the study group received hysteroscopic electroresection plus conventional progesterone treatment.
Eur J Contracept Reprod Health Care
August 2023
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.
Purpose: Laparotomic or hysteroscopic myomectomy, and high-intensity focussed ultrasound (HIFU), can be used in the treatment of Type 2 myomas with a > 50% intramural component. Hysteroscopic electroresection may damage the remaining endometrium and complete ablation of myomas may not be realised via HIFU treatment. We report and examine the results of 1 case of HIFU treatment, accompanied with the hysteroscopy endo-operative system (HEOS) cold device procedure.
View Article and Find Full Text PDFInt J Gynaecol Obstet
October 2023
Department of Gynecology and Obstetrics, Third Xiangya Hospital, Central South University, Changsha, China.
Objective: To compare and analyze the clinical efficacy and reproductive outcomes of the hysteroscopic tissue removal system (MyoSure) and hysteroscopic electroresection in the treatment of benign intrauterine lesions in women of reproductive age.
Methods: This is a retrospective study of patients with benign intrauterine lesions treated with MyoSure or hysteroscopic electroresection. The primary outcomes were operative time and resection completeness, and reproductive outcomes were followed up and compared.
Zhonghua Fu Chan Ke Za Zhi
October 2022
Hysteroscopy Centre, Obstetrics and Gynecology Hospital of Fudan University, Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China.
To analyze the clinical application and to evaluate the efficiency of hysteroscopical electroresection of International Federation of Gynecology and Obstetrics (FIGO) type 3 myoma. The clinical data of patients who underwent hysteroscopical electroresection single FIGO type 3 myoma in Obstetrics and Gynecology Hospital of Fudan University from January 2019 to October 2021 were collected retrospectively. The clinical symptoms, myoma size, location, operation time, intraoperative bleeding, surgical complications and postoperative follow-up were recorded, and the subsequent pregnancy outcomes were followed-up.
View Article and Find Full Text PDF